NFKB1 and cancer: Based upon the potential importance of NFκB activity and gene expression profiling results that implicate NFκB signaling as a target for the FGFR3 and TAK1 interaction, we evaluated the combined contribution of FGFR3 and TAK1 to NFκB activity in cancer cells using an NFκB-luciferase reporter assay.